Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCohort Regulatory News (CHRT)

Share Price Information for Cohort (CHRT)

Share Price is delayed by 15 minutes
Get Live Data
1,256.00    0.00 (0.00%)
Bid:
1,248.00
Ask:
1,282.00
Spread: 34.00 (2.724%)
Market Cap: £575.57m
CHRT Live PriceLast checked at - London Stock Exchange

Intraday Cohort Share Chart

Contract Announcement

25 Oct 2018 07:00

RNS Number : 1081F
Cohort PLC
25 October 2018
 

25 October 2018

 

Cohort plc

("Cohort" or "the Group")

 

Contract Announcement

 

MASS preferred bidder for £50m MOD contract

 

Cohort, the independent technology group, is pleased to announce that its wholly-owned subsidiary, MASS Consultants Ltd ("MASS"), has been selected as preferred bidder for an eight-year contract valued at over £50m, following a highly competitive tender process. The contract award remains subject to final negotiation and MOD approval.

 

Under the proposed contract, MASS will provide in-service support for the UK Ministry of Defence ("MOD"), including operational analysis studies, IT infrastructure management, modelling and simulation and software engineering. This is a continuation of work undertaken by MASS since 2000.

 

The contract is expected to run from April 2019 until March 2027 with a break point in March 2023. It also includes four optional one-year extension periods that, if exercised, could extend the contract until 2031.

 

Andy Thomis, Chief Executive of Cohort, said:

 

"I am delighted to announce this important result, achieved against stiff competition, which is a testament to both the quality of our bid and the excellence of our performance over the last eighteen years. To be selected as the preferred provider of this important national capability is a great vote of confidence in MASS and in the Cohort Group. Together with other recent wins, this contract, when confirmed, will enhance the visibility of future Group revenue."

 

 

Ends

 

For further information, please contact:

Cohort plc

0118 909 0390

Andy Thomis, Chief Executive

Simon Walther, Finance Director

Investec Bank Plc

020 7597 5970

Keith Anderson / Daniel Adams

MHP Communications

020 3128 8778

Reg Hoare / Ollie Hoare / Luke Briggs

 

 

NOTES TO EDITORS

Cohort plc (www.cohortplc.com) is the parent company of four innovative, agile and responsive businesses based in the UK and Portugal, providing a wide range of services and products for domestic and export customers in defence and related markets.

 

MASS is a specialist defence and technology business, focused on electronic warfare, information systems and cyber security. Acquired by Cohort in August 2006. www.mass.co.uk

 

MCL - an expert in sourcing, design and integration of communications and surveillance technology, as well as support and training for UK end users including the MOD and other government agencies. MCL has been part of the Group since July 2014. www.marlboroughcomms.com

 

SEA is an advanced electronic systems and software house operating in the defence, transport and offshore energy markets. Acquired by Cohort in October 2007.

www.sea.co.uk

 

EID designs and manufactures advanced communications systems for the defence and security markets. Cohort acquired a majority stake in June 2016. www.eid.pt

 

Cohort (AIM: CHRT) was admitted to London's Alternative Investment Market in March 2006. It has its headquarters in Berkshire and employs in total around 800 core staff there and at its other operating company sites in Bristol, Cambridgeshire, Devon, Lincolnshire, Somerset, Surrey, Scotland and Portugal.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTUSRKRWNARUAA
Date   Source Headline
16th Sep 20245:34 pmRNSHolding(s) in Company
2nd Sep 20245:08 pmRNSTotal Voting Rights
2nd Sep 202411:32 amRNSHolding(s) in Company
27th Aug 20245:54 pmRNSBlock listing six monthly return
21st Aug 20247:00 amRNSAnnual Report and Notice of Annual General Meeting
19th Aug 20243:48 pmRNSDirector/PDMR Shareholding
16th Aug 202412:10 pmRNSHolding(s) in Company
12th Aug 20244:22 pmRNSDirector/PDMR Shareholding
2nd Aug 20242:30 pmRNSDirector/PDMR Shareholding
1st Aug 202411:43 amRNSTotal Voting Rights
29th Jul 20249:45 amRNSDirector/PDMR Shareholding
23rd Jul 20245:04 pmRNSDirector/PDMR Shareholding
17th Jul 20247:01 amRNSContract win
17th Jul 20247:00 amRNSFinal Results
15th Jul 20247:00 amRNSContract Award
11th Jul 20247:00 amRNSNotice of Results
1st Jul 20249:33 amRNSTotal Voting Rights
5th Jun 202410:59 amRNSEBT Purchase of Shares
31st May 20243:17 pmRNSTotal Voting Rights
23rd May 20241:30 pmRNSEBT Purchase of Shares
23rd May 20247:00 amRNSFull Year Trading Update
20th May 20244:01 pmRNSEBT Purchase of Shares
14th May 20242:10 pmRNSEBT Purchase of Shares
7th May 20245:24 pmRNSEBT Purchase of Shares
3rd May 202411:44 amRNSDirector/PDMR Shareholding
1st May 20245:17 pmRNSDirector/PDMR Shareholding
1st May 20245:11 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSBlock Listing Application
30th Apr 20247:00 amRNSSite visit to SEA
15th Apr 20247:00 amRNSDirector/PDMR Shareholding
8th Apr 20242:19 pmRNSDirector/PDMR Shareholding
2nd Apr 20243:19 pmRNSBlock Listing Six Monthly Return
2nd Apr 20243:17 pmRNSTotal Voting Rights
28th Mar 20242:06 pmRNSHolding(s) in Company
27th Mar 20244:00 pmRNSDirector/PDMR Shareholding
26th Mar 20247:00 amRNSContract Win
19th Mar 20249:43 amRNSContract win
13th Mar 202410:49 amRNSDirector/PDMR Shareholding
1st Mar 20247:00 amRNSTotal Voting Rights
26th Feb 20244:28 pmRNSBlock listing six monthly return
16th Feb 202412:38 pmRNSDirector/PDMR Shareholding
1st Feb 202410:02 amRNSTotal Voting Rights
29th Jan 20247:00 amRNSContract Win
17th Jan 20243:25 pmRNSDirector/PDMR Shareholding
15th Jan 20247:00 amRNSInterim Report 2023
2nd Jan 202412:05 pmRNSTotal Voting Rights
22nd Dec 202312:07 pmRNSHolding(s) in Company
13th Dec 20237:01 amRNSDirectorate Change
13th Dec 20237:00 amRNSHalf Year Results
7th Dec 20237:00 amRNSEquity Development Presentation on 13 December

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.